IL6 and type 1 diabetes mellitus: Subcutaneous IL-6 administration corrected thermal hyperalgesia and tactile allodynia, improved sciatic motor and saphenous sensory NCV, and increased sciatic endoneurial perfusion in T1DM rats [129,130].